Pharmaron (03759.HK) (300759.SZ) announced that it repurchased 6,916,200 shares through centralized bidding transaction using its own funds as of the end of June, accounting for 0.39% of the current total share capital, with a per-share price ranging from RMB 18.44 to 22.27 (inclusive), and the total transaction amount is about RMB 151 million.
康龍化成(03759.HK)累斥1.51億人幣回購A股
Pharmaron (03759.HK) has cumulatively repurchased A-shares for 151 million RMB.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.